BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28445212)

  • 21. Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole.
    Glasmacher A; Hahn C; Leutner C; Molitor E; Wardelmann E; Losem C; Sauerbruch T; Marklein G; Schmidt-Wolf IG
    Mycoses; 1999; 42(7-8):443-51. PubMed ID: 10546485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma concentration of itraconazole in patients receiving chemotherapy for hematological malignancies: the effect of famotidine on the absorption of itraconazole.
    Kanda Y; Kami M; Matsuyama T; Mitani K; Chiba S; Yazaki Y; Hirai H
    Hematol Oncol; 1998 Mar; 16(1):33-7. PubMed ID: 9821410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan.
    Ohta K; Nishiki Kosaka S; Nakao Y; Kumura T; Hagihara K; Sakamoto E; Okamoto S; Hirose A; Aoyama Y; Yamamura R; Hayashi Y; Umemoto Y; Terada Y; Takeoka Y; Nakane T; Koh H; Hino M
    Int J Hematol; 2009 Jun; 89(5):649-55. PubMed ID: 19449195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prophylactic use of oral itraconazole solution for febrile neutropenia associated with hematologic malignancies].
    Nakagawa Y; Suzuki N
    Jpn J Antibiot; 2008 Apr; 61(2):102-4. PubMed ID: 18709732
    [No Abstract]   [Full Text] [Related]  

  • 25. [An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
    Tomioka H; Kaneda T; Kida Y; Kaneko M; Fujii H; Hayashi M; Tomii K; Tada K; Suzuki Y; Karino T
    Kansenshogaku Zasshi; 2011 Nov; 85(6):644-51. PubMed ID: 22250455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracranial invasive aspergillosis originating in the sphenoid sinus: a successful treatment with high-dose itraconazole in three cases.
    Yamanoi T; Shibano K; Soeda T; Hoshi A; Matsuura Y; Sugiura Y; Endo K; Yamamoto T
    Tohoku J Exp Med; 2004 Jun; 203(2):133-9. PubMed ID: 15212149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-throughput simultaneousquantification offive azole anti-fungal agents and one active metabolite in human plasma using ultra-high-performance liquid chromatography coupled to tandem mass spectrometry.
    Tanaka R; Shiraiwa K; Takano K; Ogata M; Honda S; Yoshida N; Okuhiro K; Yoshida M; Narahara K; Kai M; Tatsuta R; Itoh H
    Clin Biochem; 2022 Jan; 99():87-96. PubMed ID: 34715112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels.
    Prattes J; Duettmann W; Hoenigl M
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5595-9. PubMed ID: 27324763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children.
    de Repentigny L; Ratelle J; Leclerc JM; Cornu G; Sokal EM; Jacqmin P; De Beule K
    Antimicrob Agents Chemother; 1998 Feb; 42(2):404-8. PubMed ID: 9527794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
    Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG
    J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prophylaxis of invasive fungal infection with different administration regimens of itraconazole in patients with acute myeloid leukemia: a report from a randomized, controlled trial].
    Liu X; Huang Y; Yang DL; Wei JL; He Y; Ma QL; Pang AM; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):502-6. PubMed ID: 23827107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Itraconazole and Its Metabolite Hydroxyitraconazole on the Blood Concentrations of Cyclosporine and Tacrolimus in Lung Transplant Recipients.
    Matsuda Y; Nakagawa S; Yano I; Masuda S; Imai S; Yonezawa A; Yamamoto T; Sugimoto M; Tsuda M; Tsuzuki T; Omura T; Nakagawa T; Chen-Yoshikawa TF; Nagao M; Date H; Matsubara K
    Biol Pharm Bull; 2022; 45(4):397-402. PubMed ID: 35370263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Itraconazole-induced hypokalemia in a patient with pulmonary aspergilloma].
    Sasaki E; Maesaki S; Kawamura S; Kakeya H; Ohno H; Hirakata Y; Tomono K; Ohzono Y; Tashiro T; Kohno S
    Nihon Kokyuki Gakkai Zasshi; 1999 Jan; 37(1):36-40. PubMed ID: 10087874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
    J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic drug monitoring of itraconazole in an oncohematological pediatric patient population.
    Baietto L; G De Rosa F; Dʼavolio A; Marra C; Pace S; Biasin E; Carraro F; Nesi F; Simiele M; Cusato J; Siccardi M; Di Perri G
    Ther Drug Monit; 2012 Oct; 34(5):604-6. PubMed ID: 22972542
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical study of itraconazole for systemic fungal infections complicated with hematological malignancies--multicenter cooperative study. West-Japan Systemic Fungal Infection Study Group].
    Shiku H; Horiuchi A; Kuramoto A; Harada M; Niho Y
    Kansenshogaku Zasshi; 1998 Nov; 72(11):1208-18. PubMed ID: 9884508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of itraconazole as empirical antifungal therapy in febrile neutropenic patients with hematologic malignancies: an open-lable, multicenter, observational trial in a Chinese cohort.
    Cheng S; Zhou JF; Zou P; Huang XJ; Jin J; Shen ZX
    Chin Med J (Engl); 2011 Nov; 124(22):3670-5. PubMed ID: 22340222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetics of itraconazole in Japanese patients with invasive fungal peritonitis.
    Yamagishi Y; Hamada Y; Hagihara M; Mikamo H
    Jpn J Antibiot; 2013 Jun; 66(3):159-68. PubMed ID: 24167844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prophylaxis of fungal infection in patients with hematologic neoplasms and severe neutropenia after high-dose chemotherapy].
    Minenko SV; Zhukov NV; Chimishkian KL; Sokolova EN; Ptushkin VV
    Antibiot Khimioter; 2004; 49(8-9):52-6. PubMed ID: 15727147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study.
    Yoshida K; Kurashima A; Kamei K; Oritsu M; Ando T; Yamamoto T; Niki Y
    J Infect Chemother; 2012 Jun; 18(3):378-85. PubMed ID: 22526387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.